List of Excipients in API CHOLESTYRAMINE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing CHOLESTYRAMINE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Eon Labs Inc | cholestyramine | 0185-0940 | AMMONIUM GLYCYRRHIZATE |
| Eon Labs Inc | cholestyramine | 0185-0940 | ANHYDROUS CITRIC ACID |
| Eon Labs Inc | cholestyramine | 0185-0940 | D&C YELLOW NO. 10 |
| Eon Labs Inc | cholestyramine | 0185-0940 | FD&C YELLOW NO. 6 |
| Eon Labs Inc | cholestyramine | 0185-0940 | FRUCTOSE |
| Eon Labs Inc | cholestyramine | 0185-0940 | ORANGE |
| Eon Labs Inc | cholestyramine | 0185-0940 | PECTIN |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for CHOLESTYRAMINE
Excipient focus: ACACIA
CHOLESTYRAMINE drug variants containing ACACIA
CHOLESTYRAMINE drug variants not containing ACACIA
Excipient focus: ALUMINUM OXIDE
CHOLESTYRAMINE drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TAGI Pharma Inc | cholestyramine | 51224-011 |
| >Company | >Ingredient | >NDC |
CHOLESTYRAMINE drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIUM GLYCYRRHIZATE
CHOLESTYRAMINE drug variants containing AMMONIUM GLYCYRRHIZATE
CHOLESTYRAMINE drug variants not containing AMMONIUM GLYCYRRHIZATE
Excipient focus: ANHYDROUS CITRIC ACID
CHOLESTYRAMINE drug variants containing ANHYDROUS CITRIC ACID
CHOLESTYRAMINE drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | cholestyramine | 0245-0036 |
| Ajanta Pharma USA Inc | cholestyramine | 27241-134 |
| Physicians Total Care Inc | cholestyramine | 54868-4812 |
| >Company | >Ingredient | >NDC |
Excipient focus: ASPARTAME
CHOLESTYRAMINE drug variants containing ASPARTAME
CHOLESTYRAMINE drug variants not containing ASPARTAME
Excipient focus: CITRIC ACID ANHYDROUS
CHOLESTYRAMINE drug variants containing CITRIC ACID ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cholestyramine | 54868-4812 |
| >Company | >Ingredient | >NDC |
CHOLESTYRAMINE drug variants not containing CITRIC ACID ANHYDROUS
Excipient focus: CITRIC ACID MONOHYDRATE
CHOLESTYRAMINE drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith LaboratoriesLLC | cholestyramine | 0832-0536 |
| Ajanta Pharma USA Inc | cholestyramine | 27241-134 |
| >Company | >Ingredient | >NDC |
CHOLESTYRAMINE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CORN SYRUP
CHOLESTYRAMINE drug variants containing CORN SYRUP
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith LaboratoriesLLC | cholestyramine | 0832-0536 |
| >Company | >Ingredient | >NDC |
CHOLESTYRAMINE drug variants not containing CORN SYRUP
Excipient focus: D&C RED NO. 30
CHOLESTYRAMINE drug variants containing D&C RED NO. 30
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | cholestyramine for oral suspension | 62135-008 |
| >Company | >Ingredient | >NDC |
CHOLESTYRAMINE drug variants not containing D&C RED NO. 30
Excipient focus: D&C YELLOW NO. 10
CHOLESTYRAMINE drug variants containing D&C YELLOW NO. 10
CHOLESTYRAMINE drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | cholestyramine | 0245-0036 |
| Upsher-Smith LaboratoriesLLC | cholestyramine | 0832-0536 |
| TAGI Pharma Inc | cholestyramine | 51224-009 |
| TAGI Pharma Inc | cholestyramine | 51224-011 |
| Chartwell RX LLC | cholestyramine for oral suspension | 62135-008 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
CHOLESTYRAMINE drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith LaboratoriesLLC | cholestyramine | 0832-0536 |
| TAGI Pharma Inc | cholestyramine | 51224-009 |
| TAGI Pharma Inc | cholestyramine | 51224-011 |
| >Company | >Ingredient | >NDC |
CHOLESTYRAMINE drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: FD&C RED NO. 40
CHOLESTYRAMINE drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | cholestyramine | 63629-2161 |
| Bryant Ranch Prepack | cholestyramine | 63629-2162 |
| Bryant Ranch Prepack | cholestyramine | 72162-1505 |
| >Company | >Ingredient | >NDC |
CHOLESTYRAMINE drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
CHOLESTYRAMINE drug variants containing FD&C YELLOW NO. 6
CHOLESTYRAMINE drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith LaboratoriesLLC | cholestyramine | 0832-0536 |
| Bryant Ranch Prepack | cholestyramine | 63629-2161 |
| Bryant Ranch Prepack | cholestyramine | 63629-2162 |
| Bryant Ranch Prepack | cholestyramine | 72162-1505 |
| Chartwell RX LLC | cholestyramine for oral suspension | 62135-008 |
| >Company | >Ingredient | >NDC |
Excipient focus: FRUCTOSE
CHOLESTYRAMINE drug variants containing FRUCTOSE
CHOLESTYRAMINE drug variants not containing FRUCTOSE
Excipient focus: MALIC ACID
CHOLESTYRAMINE drug variants containing MALIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | cholestyramine | 0245-0036 |
| >Company | >Ingredient | >NDC |
CHOLESTYRAMINE drug variants not containing MALIC ACID
Excipient focus: MALTODEXTRIN
CHOLESTYRAMINE drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith LaboratoriesLLC | cholestyramine | 0832-0536 |
| Bryant Ranch Prepack | cholestyramine | 63629-2161 |
| Bryant Ranch Prepack | cholestyramine | 63629-2162 |
| Bryant Ranch Prepack | cholestyramine | 72162-1505 |
| >Company | >Ingredient | >NDC |
CHOLESTYRAMINE drug variants not containing MALTODEXTRIN
Excipient focus: MANNITOL
CHOLESTYRAMINE drug variants containing MANNITOL
CHOLESTYRAMINE drug variants not containing MANNITOL
Excipient focus: ORANGE
CHOLESTYRAMINE drug variants containing ORANGE
CHOLESTYRAMINE drug variants not containing ORANGE
Excipient focus: PECTIN
CHOLESTYRAMINE drug variants containing PECTIN
CHOLESTYRAMINE drug variants not containing PECTIN
Excipient focus: POLYSORBATE 80
CHOLESTYRAMINE drug variants containing POLYSORBATE 80
CHOLESTYRAMINE drug variants not containing POLYSORBATE 80
Excipient focus: PROPYLENE GLYCOL ALGINATE
CHOLESTYRAMINE drug variants containing PROPYLENE GLYCOL ALGINATE
CHOLESTYRAMINE drug variants not containing PROPYLENE GLYCOL ALGINATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
CHOLESTYRAMINE drug variants containing SILICON DIOXIDE
CHOLESTYRAMINE drug variants not containing SILICON DIOXIDE
Excipient focus: SORBITOL
CHOLESTYRAMINE drug variants containing SORBITOL
CHOLESTYRAMINE drug variants not containing SORBITOL
Excipient focus: STARCH, CORN
CHOLESTYRAMINE drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith LaboratoriesLLC | cholestyramine | 0832-0536 |
| >Company | >Ingredient | >NDC |
CHOLESTYRAMINE drug variants not containing STARCH, CORN
Excipient focus: SUCROSE
CHOLESTYRAMINE drug variants containing SUCROSE
CHOLESTYRAMINE drug variants not containing SUCROSE
Excipient focus: TOCOPHEROL
CHOLESTYRAMINE drug variants containing TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith LaboratoriesLLC | cholestyramine | 0832-0536 |
| >Company | >Ingredient | >NDC |
CHOLESTYRAMINE drug variants not containing TOCOPHEROL
Excipient focus: VANILLA
CHOLESTYRAMINE drug variants containing VANILLA
CHOLESTYRAMINE drug variants not containing VANILLA
Excipient focus: XANTHAN GUM
CHOLESTYRAMINE drug variants containing XANTHAN GUM
CHOLESTYRAMINE drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
